搜索公司,投资者……
Natera公司标志

Natera

natera.com

Natera没有声称他们的个人资料。

4 Natera的竞争对手已经声称他们的。

这是他们的竞争对手在说什么:

Natera标志

基因表达自称是更好的解决方案Natera由于:

专注于DNA测序

Natera标志

千变万化的BioDiagnostics自称是更好的解决方案Natera由于:

最小的产品,没有实际价值的病人

Natera标志

C2i基因组学自称是更好的解决方案Natera由于:

全基因组与小面板

Natera替代品和竞争对手

看看Natera比较类似的产品。Natera最主要的竞争对手包括Biohope,个人基因组诊断,C2i基因组学

Biohope标志

Biohope致力于发展的诊断和治疗肾移植患者的免疫学临床管理的解决方案,与潜在的…

Natera与Biohope

更深入的数据视图:

  • 竞争对手
  • 产品
  • 客户引用和更多

与Natera竞争?

短暂的我们的分析师。

在科技面前买家。

100%免费的。

没有商界无稽之谈。

比较Natera竞争对手

J
JJET

JJET致力于开发、生产和销售的产品领域的电生理学;产品主要包括三维心脏映射系统,多道生理记录仪,心脏电生理刺激,心脏射频消融设备,冷盐水灌注泵、心脏电生理导管的映射,心脏射频消融导管,神经射频治疗仪器。公司成立于1991年,总部设在成都,中国。

R
Rubicor医疗

Rubicor医疗是一个私人医疗设备公司位于红木市,加利福尼亚。我们的专有活检技术(鼓掌乳房活检设备)是一个戏剧性的改善当前微创活检技术。14号的Ovation系统由活检设备切割的能力,捕捉和提取完整的2.5厘米直径的组织样本。热烈欢迎兼容超声波或立体定向形象指导。Rubicor由詹姆斯检查者和博士已经与私人资助的个人投资者组成的财团。詹姆斯·w .检查者,医学博士,CEO and Chairman of the Board, is a board certified interventional cardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of the Medical College of Wisconsin where he completed a residency in internal medicine and a fellowship in cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John Simpson M.D./PhD., at Sequoia Hospital, Redwood City, California. Dr. Vetter is a member of the Alpha Omega Alpha Honor Society and the American College of Cardiologists. He has published six articles and several book chapters as well as over 35 abstracts. Dr. Vetter has held positions as a member of the Physician Advisory Council and/or board member with a number of medical device companies including Guidant, Lumend, Fox Hollow and CardioVasc. He is also a board member of Magellan Systems International, Inc. Dr. Vetter has extensive experience in working with new medical device concepts and designs, working with R&D engineers to develop working prototypes and clinically testing and refining those products. He was co-founder of Perclose and was involved with that company from inception to initial public offering and eventual sale to Abbott Labs. He is a "hands on" clinician with access to resources and expertise needed to build a successful medical device and company. Dr. Vetter has had a number of patents issued in his name as co-inventor. Ary Chernomorsky, V.P. of R&D since 2000 has over 23 years experience in the medical device industry. Prior to joining Rubicor, Mr. Chernomorsky was employed by the Vascular Therapies division of US Surgical Company (acquired by Tyco International), where he served as a Director of R&D. Mr. Chernomorsky has been involved with various startup companies in the R&D Director and Manager capacities including: PAS Inc. (acquired by USS), Advanced Surgical, Inc. (acquired by Imagyn), Micro Therapeutics, Bausch and Lomb, Mentor Corporation and Dart Industries Inc. Ary holds an M.S. in Polymer Engineering from LIT and an M.S. in Biomedical Engineering from Rutgers University. Tony Difede, CPA, V.P. Finance holds a BSBA degree in Accounting from the University of Florida and a M.S. in Taxation from Pace University. He has held management positions in tax and accounting with Ernst & Young, KPMG and my CFO, Inc. His clients have included closely held start-up companies as well as large multinational public corporations. He is licensed in California and New Jersey. He has extensive experience in accounting for stock options and issues regarding closely held companies and their high net worth owners and investors. COMPANY INFO MANAGEMENT page 1 2006 Company Overview (Continued) Breast care. Completely redefined. James W. Vetter, M.D., Founder and Chairman of the Board, is a board certified interventional cardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of the Medical College of Wisconsin where he completed a residency in internal medicine and a fellowship in cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John Simpson M.D./PhD., at Sequoia Hospital, Redwood City, Cal

C
哥伦比亚大学生物系统

哥伦比亚大学生物系统公司是一家从事分子Nano-diagnostics使用分子印迹聚合物(MIPs)等病原体的快速检测耐甲氧西林金黄色葡萄球菌(MRSA),炭疽,艾滋病毒,和锥虫病(昏睡病)。公司采用MIPs结合蛋白质,在绑定,从而改变颜色信号的存在细菌、病毒或寄生虫。

年代
StageMark

StageMark医疗保健公司,打算提供一个早期识别和炎症性疾病,如红斑狼疮的监控解决方案。

小噬细胞

小噬细胞的使命是成为一个在全球范围内快速的细菌诊断的先驱,在细菌鉴定和药敏/电阻测试,通过其bacteriophage-based放大免疫测定诊断平台。

F
Flex生物医学

Flex生物医学发展技术能帮助我们找到诊断和治疗骨科疾病。Flex生物医学的主要产品是合成聚合物,Flex聚合物,用于治疗骨关节炎。

发现正确的解决方案为您的团队

CB见解德赢体育vwin官方网站科技市场情报平台分析数百万数据点在供应商、产品、合作关系,专利来帮助您的团队发现他们的下一个技术解决方案。

请求一个演示

CBI的网站通常使用一些饼干,使更好的相互作用我们的网站和服务。使用这些饼干,这可能是存储在你的设备上,允许我们的改进和定制你的经历。你可以阅读更多关于你的饼干的选择在我们的隐私政策在这里。继续使用这个你同意这些选择。

Baidu
map